Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aminoacyltransferases | 2 | 2018 | 50 | 0.750 |
Why?
|
| Cysteine Endopeptidases | 3 | 2021 | 548 | 0.680 |
Why?
|
| Receptors, LDL | 1 | 2021 | 488 | 0.650 |
Why?
|
| Peptidyl Transferases | 1 | 2018 | 55 | 0.620 |
Why?
|
| Erythroid Precursor Cells | 3 | 2017 | 211 | 0.590 |
Why?
|
| CD8-Positive T-Lymphocytes | 5 | 2024 | 4550 | 0.550 |
Why?
|
| Hyperlipidemias | 1 | 2021 | 782 | 0.550 |
Why?
|
| Antigen Presentation | 1 | 2022 | 1254 | 0.540 |
Why?
|
| Peptides | 5 | 2022 | 4354 | 0.520 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2021 | 825 | 0.510 |
Why?
|
| Down-Regulation | 1 | 2021 | 2913 | 0.470 |
Why?
|
| Erythropoiesis | 2 | 2018 | 682 | 0.460 |
Why?
|
| Immune Tolerance | 2 | 2021 | 2299 | 0.430 |
Why?
|
| Cholesterol, LDL | 1 | 2021 | 2420 | 0.400 |
Why?
|
| Influenza, Human | 1 | 2022 | 1528 | 0.380 |
Why?
|
| Melanoma, Experimental | 4 | 2021 | 562 | 0.320 |
Why?
|
| Major Histocompatibility Complex | 2 | 2022 | 928 | 0.310 |
Why?
|
| Bacterial Proteins | 2 | 2018 | 3825 | 0.300 |
Why?
|
| Erythrocytes | 4 | 2021 | 2415 | 0.300 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2022 | 1446 | 0.290 |
Why?
|
| Histocompatibility Antigens Class I | 3 | 2024 | 1355 | 0.290 |
Why?
|
| Erythrocyte Membrane | 2 | 2021 | 439 | 0.280 |
Why?
|
| Protein Engineering | 2 | 2021 | 541 | 0.270 |
Why?
|
| Antigens | 2 | 2022 | 1447 | 0.260 |
Why?
|
| Erythroblasts | 2 | 2018 | 143 | 0.260 |
Why?
|
| Immunity, Cellular | 2 | 2021 | 1557 | 0.250 |
Why?
|
| Mice | 21 | 2022 | 81209 | 0.240 |
Why?
|
| Genetic Engineering | 2 | 2021 | 933 | 0.230 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2021 | 3734 | 0.210 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 3604 | 0.210 |
Why?
|
| Hemagglutinins | 1 | 2022 | 113 | 0.210 |
Why?
|
| Camelids, New World | 1 | 2021 | 20 | 0.200 |
Why?
|
| Mannans | 1 | 2022 | 58 | 0.200 |
Why?
|
| Antigen-Presenting Cells | 2 | 2024 | 967 | 0.200 |
Why?
|
| Carbon-Nitrogen Ligases | 1 | 2021 | 27 | 0.190 |
Why?
|
| Pandemics | 1 | 2021 | 8623 | 0.190 |
Why?
|
| Monitoring, Immunologic | 1 | 2021 | 98 | 0.190 |
Why?
|
| Influenza A virus | 2 | 2021 | 457 | 0.190 |
Why?
|
| Animals | 23 | 2024 | 167960 | 0.180 |
Why?
|
| Amino Acid Sequence | 3 | 2021 | 13451 | 0.170 |
Why?
|
| Histocompatibility | 1 | 2021 | 316 | 0.170 |
Why?
|
| Catalysis | 2 | 2018 | 775 | 0.170 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2020 | 1455 | 0.170 |
Why?
|
| Antibodies, Neutralizing | 4 | 2022 | 1933 | 0.170 |
Why?
|
| Immunization, Secondary | 1 | 2021 | 366 | 0.160 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2021 | 250 | 0.160 |
Why?
|
| Candida albicans | 1 | 2022 | 374 | 0.160 |
Why?
|
| Tumor Microenvironment | 4 | 2020 | 3844 | 0.160 |
Why?
|
| Transduction, Genetic | 1 | 2021 | 897 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 10 | 2022 | 22020 | 0.160 |
Why?
|
| Positron-Emission Tomography | 3 | 2024 | 6465 | 0.150 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2018 | 142 | 0.150 |
Why?
|
| Antigens, Viral | 1 | 2022 | 980 | 0.150 |
Why?
|
| Phosphorylcholine | 1 | 2018 | 153 | 0.150 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2021 | 530 | 0.140 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 604 | 0.140 |
Why?
|
| Autoantigens | 1 | 2021 | 877 | 0.140 |
Why?
|
| Polyethylene Glycols | 1 | 2022 | 1189 | 0.140 |
Why?
|
| Adjuvants, Immunologic | 1 | 2022 | 1039 | 0.130 |
Why?
|
| Immunotherapy | 3 | 2024 | 4642 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 2 | 2021 | 6216 | 0.130 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1088 | 0.130 |
Why?
|
| Receptors, Immunologic | 1 | 2021 | 1414 | 0.120 |
Why?
|
| Dexamethasone | 1 | 2022 | 1927 | 0.120 |
Why?
|
| Precancerous Conditions | 1 | 2021 | 977 | 0.120 |
Why?
|
| Molecular Imaging | 1 | 2021 | 818 | 0.120 |
Why?
|
| Substrate Specificity | 1 | 2018 | 1792 | 0.120 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2017 | 229 | 0.110 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 3142 | 0.110 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2022 | 1869 | 0.110 |
Why?
|
| Reticulocytes | 1 | 2014 | 288 | 0.110 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2018 | 498 | 0.110 |
Why?
|
| Stem Cell Transplantation | 1 | 2021 | 1601 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2022 | 1796 | 0.110 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 1447 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2021 | 4263 | 0.100 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 9530 | 0.100 |
Why?
|
| Gene Deletion | 2 | 2018 | 2668 | 0.100 |
Why?
|
| Microarray Analysis | 1 | 2014 | 747 | 0.090 |
Why?
|
| Antigens, CD | 1 | 2021 | 4000 | 0.090 |
Why?
|
| Body Weight | 1 | 2021 | 4611 | 0.090 |
Why?
|
| Soft Tissue Injuries | 1 | 2012 | 172 | 0.090 |
Why?
|
| Inflammation | 3 | 2022 | 10755 | 0.090 |
Why?
|
| Osteopontin | 1 | 2012 | 302 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2021 | 18955 | 0.090 |
Why?
|
| Recombinant Proteins | 1 | 2020 | 6538 | 0.090 |
Why?
|
| Species Specificity | 1 | 2014 | 2418 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2021 | 3663 | 0.080 |
Why?
|
| Cytokines | 3 | 2021 | 7344 | 0.080 |
Why?
|
| Staphylococcus aureus | 1 | 2017 | 1462 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4353 | 0.080 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2018 | 1634 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 3075 | 0.070 |
Why?
|
| Humans | 17 | 2024 | 760613 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2014 | 5039 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 3390 | 0.070 |
Why?
|
| Epitopes | 2 | 2022 | 2503 | 0.060 |
Why?
|
| Apoptosis | 1 | 2021 | 9497 | 0.060 |
Why?
|
| Skin Neoplasms | 2 | 2021 | 5799 | 0.060 |
Why?
|
| Erythrocyte Transfusion | 2 | 2021 | 566 | 0.060 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2024 | 95 | 0.060 |
Why?
|
| Regeneration | 1 | 2012 | 1506 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2014 | 5869 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2021 | 3205 | 0.050 |
Why?
|
| Macrophages | 2 | 2022 | 5745 | 0.050 |
Why?
|
| Melanoma | 1 | 2021 | 5697 | 0.050 |
Why?
|
| Macaca fascicularis | 1 | 2024 | 900 | 0.050 |
Why?
|
| Transcription Factor RelB | 1 | 2022 | 28 | 0.050 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 18137 | 0.050 |
Why?
|
| Aluminum Hydroxide | 1 | 2022 | 54 | 0.050 |
Why?
|
| Oldenlandia | 1 | 2021 | 2 | 0.050 |
Why?
|
| beta-Glucans | 1 | 2022 | 121 | 0.050 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2021 | 158 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2018 | 11481 | 0.050 |
Why?
|
| Vero Cells | 1 | 2022 | 482 | 0.050 |
Why?
|
| Membrane Fusion | 1 | 2022 | 266 | 0.050 |
Why?
|
| Single-Chain Antibodies | 1 | 2021 | 111 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2021 | 224 | 0.050 |
Why?
|
| Cell Tracking | 1 | 2021 | 138 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5659 | 0.040 |
Why?
|
| Solubility | 1 | 2022 | 1088 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 5349 | 0.040 |
Why?
|
| Molecular Probes | 1 | 2021 | 313 | 0.040 |
Why?
|
| rho-Associated Kinases | 1 | 2021 | 281 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2022 | 1060 | 0.040 |
Why?
|
| Lung | 3 | 2024 | 9994 | 0.040 |
Why?
|
| Pregnancy | 1 | 2021 | 29746 | 0.040 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2022 | 545 | 0.040 |
Why?
|
| Paranasal Sinuses | 1 | 2022 | 265 | 0.040 |
Why?
|
| Plant Proteins | 1 | 2021 | 370 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 16932 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2022 | 587 | 0.040 |
Why?
|
| Granzymes | 1 | 2020 | 276 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2022 | 943 | 0.040 |
Why?
|
| Interferons | 1 | 2022 | 705 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 9406 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2021 | 23374 | 0.040 |
Why?
|
| Elastic Modulus | 1 | 2018 | 210 | 0.040 |
Why?
|
| Whole-Body Irradiation | 1 | 2018 | 433 | 0.040 |
Why?
|
| Botulism | 1 | 2017 | 21 | 0.040 |
Why?
|
| Immunization | 1 | 2022 | 1227 | 0.040 |
Why?
|
| Gamma Rays | 1 | 2018 | 317 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 4924 | 0.040 |
Why?
|
| Protein Binding | 2 | 2021 | 9335 | 0.040 |
Why?
|
| Female | 5 | 2021 | 391246 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2021 | 547 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 13262 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2021 | 1895 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 1837 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2021 | 1870 | 0.030 |
Why?
|
| Dogs | 1 | 2021 | 3841 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2021 | 1666 | 0.030 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2018 | 413 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2021 | 2627 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 495 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 2017 | 393 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2021 | 3607 | 0.030 |
Why?
|
| Neoplasms | 1 | 2024 | 22075 | 0.030 |
Why?
|
| Retroviridae | 1 | 2017 | 850 | 0.030 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2021 | 1112 | 0.030 |
Why?
|
| Ligands | 1 | 2022 | 3276 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2017 | 929 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2018 | 1342 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2021 | 1354 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2021 | 14374 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1792 | 0.030 |
Why?
|
| Glycolysis | 1 | 2018 | 828 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 1229 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 1881 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 1347 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2018 | 928 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 1993 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2017 | 1535 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2021 | 5434 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1652 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3583 | 0.020 |
Why?
|
| Leukocytes | 1 | 2018 | 2027 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2022 | 3486 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2022 | 3047 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2018 | 2063 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2018 | 6359 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2022 | 4742 | 0.020 |
Why?
|
| Anemia | 1 | 2017 | 1511 | 0.020 |
Why?
|
| Cell Survival | 1 | 2018 | 5797 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2017 | 3380 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2018 | 2519 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 11070 | 0.020 |
Why?
|
| Cell Line | 1 | 2021 | 15620 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2021 | 3527 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 3709 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2803 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2021 | 8022 | 0.020 |
Why?
|
| Gene Expression | 1 | 2018 | 7587 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 10185 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3802 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4571 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 9185 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 10181 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15840 | 0.010 |
Why?
|
| Mutation | 1 | 2021 | 29957 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 13627 | 0.010 |
Why?
|
| Age Factors | 1 | 2012 | 18413 | 0.010 |
Why?
|
Concepts
(202)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(42)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_